Furthermore, blockade of DNMT1 because of icaritin treatment was previously indicated to increase miR-124 levels in human oral squamous cell carcinoma cells (Jin et al., 2017). The gene discussed is DNMT1; the disease is oral cavity squamous cell carcinoma.